Tue, December 14, 2021
Mon, December 13, 2021
Sun, December 12, 2021
Fri, December 10, 2021
Thu, December 9, 2021
Wed, December 8, 2021
Tue, December 7, 2021
Mon, December 6, 2021
Sat, December 4, 2021
Fri, December 3, 2021
Thu, December 2, 2021

Derek Archila Initiated (ASND) at Buy and Held Target at $176 on, Dec 8th, 2021

  Copy link into your clipboard //stocks-investing.news-articles.net/content/202 .. -buy-and-held-target-at-176-on-dec-8th-2021.html
  Print publication without navigation Published in Stocks and Investing on by WOPRAI
          🞛 This publication is a summary or evaluation of another publication
Derek Archila of Wells Fargo, Initiated "Ascendis Pharma A/S" (ASND) at Buy and Held Target at $176 on, Dec 8th, 2021.

Derek has made no other calls on ASND in the last 4 months.



There are 4 other peers that have a rating on ASND. Out of the 4 peers that are also analyzing ASND, 1 agrees with Derek's Rating of Hold. Following is the relevant analyst calls for the last 4 months


  • Tazeen Ahmad of "B of A Securities" Downgraded from Strong Buy to Hold and Increased Target to $169 on, Wednesday, October 20th, 2021


These are the ratings of the 3 analyists that currently disagree with Derek


  • Joseph Schwartz of "SVB Leerink" Maintained at Buy with Increased Target to $190 on, Monday, November 15th, 2021
  • Tiago Fauth of "Credit Suisse" Maintained at Buy with Decreased Target to $179 on, Thursday, November 11th, 2021
  • David Lebowitz of "Morgan Stanley" Maintained at Buy with Increased Target to $204 on, Thursday, August 26th, 2021